These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluating Sex Differences in the Effect of Increased Systolic Blood Pressure on the Risk of Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis. Lin YT; Chen YR; Wei YC Glob Heart; 2022; 17(1):70. PubMed ID: 36382163 [TBL] [Abstract][Full Text] [Related]
24. Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Radenković M; Stojanović M; Prostran M Curr Med Chem; 2019; 26(29):5579-5595. PubMed ID: 30009701 [TBL] [Abstract][Full Text] [Related]
25. A systematic review and meta-analysis of early diagnosis and treatment of hypertensive stroke under calcium channel blockers. Feng A; Wang W; Du C; He M Ann Palliat Med; 2021 Jun; 10(6):6715-6725. PubMed ID: 34237974 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis. Jeffers BW; Robbins J; Bhambri R Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586 [TBL] [Abstract][Full Text] [Related]
27. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness. Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415 [TBL] [Abstract][Full Text] [Related]
28. The influence of one-year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension--comparison with calcium channel blockers. Munakata M; Aihara A; Nunokawa T; Ito N; Imai Y; Ito S; Yoshinaga K Clin Exp Hypertens; 2003 Apr; 25(3):169-81. PubMed ID: 12716079 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712 [TBL] [Abstract][Full Text] [Related]
33. Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: subanalysis of the OSCAR study. Kim-Mitsuyama S; Ogawa H; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K; Hypertens Res; 2015 Mar; 38(3):199-207. PubMed ID: 25471234 [TBL] [Abstract][Full Text] [Related]
34. Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis. Francischetti EA; de Abreu VG; da Silva Figueiredo LF; Dezonne RS; Coutinho ESF Am J Cardiovasc Drugs; 2020 Oct; 20(5):447-470. PubMed ID: 31898196 [TBL] [Abstract][Full Text] [Related]
35. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178 [TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy. Ma J; Wang XY; Hu ZD; Zhou ZR; Schoenhagen P; Wang H J Thorac Dis; 2015 Dec; 7(12):2243-52. PubMed ID: 26793346 [TBL] [Abstract][Full Text] [Related]
37. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis. Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438 [TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and blood pressure: a GRADE-assessed systematic review and dose-response meta-analysis of 41,633 participants. Asbaghi O; Salehpour S; Rezaei Kelishadi M; Bagheri R; Ashtary-Larky D; Nazarian B; Mombaini D; Ghanavati M; Clark CCT; Wong A; Naeini AA Crit Rev Food Sci Nutr; 2023; 63(13):1846-1861. PubMed ID: 34478339 [TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up. Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103 [TBL] [Abstract][Full Text] [Related]
40. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]